April 05, 2022

Roadmap Preview: Biomarker-Guided And Pharmacogenomic-Informed Dosing

On our Year in Review webinar, presenters Stephanie Hughes, PharmD, BCIDP, Clinical Applications Specialist, and Jon Faldasz, PharmD, BCPS, our Senior Director of Product & Customer Experience, shared a sneak peek at an exciting expansion on the horizon. In 2022, InsightRX will extend the InsightRX Nova platform beyond therapeutic drug monitoring (TDM) into two other categories: biomarker-guided dosing and pharmacogenomic-informed dosing.

Read Full Article
Filter By:

Apply Filters

Category
No resource was found.
Roadmap Preview: Biomarker-Guided And Pharmacogenomic-Informed Dosing
April 05, 2022

Roadmap Preview: Biomarker-Guided And Pharmacogenomic-Informed Dosing

Learn More
Roadmap Preview: Bringing Precision Dosing To New Therapeutic Areas
March 24, 2022

Roadmap Preview: Bringing Precision Dosing To New Therapeutic Areas

Learn More